title: In regard to Zhou et al "Baseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasis" (Int J Radiat Oncol Biol Phys 2012;82:e359-e365).
authors.forename: Enis
authors.initials: E
authors.lastname: Ozyar
authors.forename: Hale Basak
authors.initials: HB
authors.lastname: Caglar
authors.forename: Banu
authors.initials: B
authors.lastname: Atalar
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D002277:Carcinoma / Q000097:blood*; D005260:Female; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008113:Liver Neoplasms / Q000556:secondary*; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000097:blood*; D050397:Radiotherapy, Intensity-Modulated
chemical_list: D014408:Biomarkers, Tumor; D007770:L-Lactate Dehydrogenase